DCT
1:21-md-03017
In re: Xarelto (Rivaroxaban) ('310) Patent Litigation
General
Filed
12/10/21
Cause of ActionPatent Infringement
SectorBiotech
StatusOpen
Patent Owner
Operating Company (W)
PACER
1:21-md-03017
Nature of Suit835 ANDA
CourtD. Delaware
| Judge | Period | PO Win Rate | 
|---|---|---|
| 11/01/23 - now | 36% | |
| 10/04/23 - 11/01/23 | -- | |
| 12/28/21 - 10/04/23 | 36% | 
Plaintiff
Attorney
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L5 A | |
| L5 A | |
| L5 B | |
| L3 B | |
| -- -- -- | |
| -- -- -- | |
| Robinson MillerLocal | L3 A | 
| L5 E | |
| L3 C | |
| L5 A | |
| L4 A | |
| L1 B | |
| L1 C | |
| L1 D | |
| -- -- -- | |
| -- -- -- | 
No Attorneys
Defendant
Party
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L5 E | |
| L4 E | |
| L4 E | |
| L4 E | |
| L4 E | |
| L3 E | |
| L2 E | |
| L2 E | |
| L2 E | |
| L1 D | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | 
No Parties
Attorney
| Name | Ratings | 
|---|---|
| L5 A | |
| L5 A | |
| L4 B | |
| L5 A | |
| L5 A | |
| L5 A | |
| L5 E | |
| L5 B | |
| L5 E | |
| Shaw Keller LLPLocal | L4 D | 
| L5 C | |
| L4 E | |
| L2 E | |
| L2 E | |
| -- -- -- | |
| -- -- -- | |
| -- -- -- | |
| Morris James LLPLocal | L4 E | 
| L5 E | |
| L2 A | |
| L4 E | |
| L4 C | |
| L2 A | |
| L4 E | |
| L5 E | |
| L5 E | |
| L3 B | |
| -- -- -- | |
| L3 C | |
| L5 D | |
| L4 A | |
| L4 B | |
| L4 C | |
| L2 A | |
| L1 C | |
| L1 D | |
| L3 D | |
| L3 E | |
| L2 D | |
| L3 D | |
| L5 A | |
| L3 A | |
| -- -- -- | |
| L3 E | |
| L5 E | |
| L2 A | |
| L2 E | |
| L1 E | |
| -- -- -- | |
| -- -- -- | |
| L3 E | |
| L5 E | |
| L3 E | |
| L5 E | |
| L5 E | |
| Abrams & Bayliss LLPLocal | L2 D | 
| L4 E | |
| L1 D | |
| -- -- -- | |
| L2 E | |
| L4 C | |
| L2 B | |
| L2 E | |
| -- -- -- | |
| Rogowski LawLocal | L1 C | 
| L1 C | |
| L1 E | |
| L4 E | |
| L4 E | |
| L3 E | |
| L3 E | |
| James S Green JRLocal | -- -- -- | 
| L1 C | 
No Attorneys